Let Charts Inform You
Health Care: Drugs
Immunogen Inc. (IMGN: NASDAQ)
$14.41 -0.08 | -0.55%
02/08/12 - 03:05 PM ET
371.30K / 464.60K
Vol / Avg. Vol:14.54 / 14.49
Open / Prev. Close:14.07 - 14.69
Today's Range:8.31 - 16.20
52 Wk Range:25.13%
Performance YTD:TheStreet Rating:
Portfolios with IMGN
- Portfolio NameUser Type
- ContributorEarnings Short Squeeze Play...
- UserJKE 1
- UserWatch List - Healthcare / B...
- UserCR
- UserASCO 2010
- UserPART 7 JPMorgan 28th Annual...
- UserStockPot
- ContributorCramer's 4 Biotech Plays
- ContributorCramer's Cancer Takeover Ta...
- ContributorCramer's Cancer-Fighting St...
Latest IMGN Headlines from TheStreet
- Cramer's 'Mad Money' Recap: Winning Themes (Final) 10.26.11 | 07:10 pm
- 'Mad Money Lightning Round': Go for Intuitive Surgical 10.26.11 | 07:10 pm
- 3 Stocks I Saw on TV, September 27
09.27.11 | 08:09 am - The Next Big Thing In Biotech: Immunogen 09.09.11 | 05:09 am
- 8 Stocks That Could Surge on Earnings 08.03.11 | 11:08 am
- Stocks Under $10: Biotech Bargain Play 06.22.11 | 09:06 am
- Immunogen Stock Falls On Unusually High Volume (IMGN) 05.20.11 | 10:05 am
- XenoPort, Rite Aid: Small-Cap Winners 04.07.11 | 12:04 pm
- ImmunoGen CEO Discusses F1Q11 Results - Earnings Call Transcript 10.29.10 | 03:10 am
- Cramer's 'Mad Money' Recap: Picking the Best in Breed (Final) 10.28.10 | 07:10 pm
Press Releases for IMGN
- ImmunoGen, Inc. Announces Webcast Of Presentations At Upcoming Investor Conferences - Business Wire 02.07.12 | 06:02 am
- ImmunoGen, Inc. Announces Conference Call To Discuss Its Second Quarter Fiscal Year 2012 Financial Results - Business Wire 01.18.12 | 02:01 pm
- ImmunoGen, Inc. Announces Conference Call To Discuss Its First Quarter Fiscal Year 2012 Financial Results - Business Wire 10.20.11 | 06:10 am
- ImmunoGen, Inc. Announces Webcast Of Presentation At The Canaccord Genuity 31st Annual Growth Conference - Business Wire 08.05.11 | 06:08 am
- ImmunoGen, Inc. Reports Fourth Quarter And Fiscal Year 2011 Financial Results And Provides Corporate Update And Fiscal Year 2012 Guidance - Business Wire 08.03.11 | 04:08 pm
- ImmunoGen, Inc. Announces Conference Call To Discuss Its Fourth Quarter And Fiscal Year 2011 Financial Results - Business Wire 07.28.11 | 06:07 am
- ImmunoGen, Inc. Earns Milestone With BAY 94-9343 IND Submission - Business Wire 06.14.11 | 04:06 pm
- ImmunoGen, Inc. Announces Positive Clinical Data Presented On IMGN901 In The Treatment Of Multiple Myeloma - Business Wire 06.05.11 | 12:06 pm
- ImmunoGen, Inc. Announces Presentation Of Favorable SAR3419 Interim Clinical Data At ASCO - Business Wire 06.04.11 | 09:06 am
- ImmunoGen, Inc. Announces Webcast Of Presentation At Jefferies 2011 Global Healthcare Conference - Business Wire 06.01.11 | 11:06 am
Partner Headlines for IMGN
- 10 Biotech Stocks With Strong Corporate Governance - Seeking Alpha 01.18.12 | 09:01 am
- Roche Reports Positive Data - Analyst Blog - Zacks 09.30.11 | 10:09 am
- ImmunoGen/Roche Breast Cancer Treatment Shows Promising Results - Benzinga 09.24.11 | 06:09 pm
- Spectrum Pharmaceuticals: A Great Biotech Company For Around $8 - Seeking Alpha 08.26.11 | 05:08 am
- 3 Biotech Stocks Predictive Analysts Expect to Outperform - Seeking Alpha 07.24.11 | 08:07 am
- Company News for July 7, 2011 - Corporate Summary - Zacks 07.07.11 | 10:07 am
- Drugs to Watch at ASCO 2011 - Seeking Alpha 06.02.11 | 08:06 am
- Company News for April 11, 2011 - Corporate Summary - Zacks 04.11.11 | 10:04 am
- 27 Stocks Worth Watching That Hit 52 Week Highs Last Friday - Seeking Alpha 04.11.11 | 08:04 am
- Company News for April 08, 2011 - Corporate Summary - Zacks 04.08.11 | 10:04 am
